(Q64137268)

English

Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

0 references

invasive pneumococcal disease

0 references

pneumococcal conjugate vaccine

0 references

0 references

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

7

object named as

Allison McGeer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

George G Zhanel

9

object named as

George G Zhanel

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Jonathan B Gubbay

10

object named as

Jonathan Gubbay

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Michael R. Mulvey

20

object named as

Michael R Mulvey

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Gregory J. Tyrrell

8

object named as

Gregory J Tyrrell

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

author name string

Walter H B Demczuk

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Irene Martin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Shalini Desai

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Averil Griffith

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Laurence Caron-Poulin

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Brigitte Lefebvre

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Linda Hoang

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Paul N Levett

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Paul Van Caeseele

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Rita Raafat Gad

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

David Haldane

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

George Zahariadis

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Gregory German

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Jennifer Daley Bernier

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Lori Strudwick

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

language of work or name

0 references

publication date

21 June 2018

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

4701-4707

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Pneumococcal Capsules and Their Types: Past, Present, and Future

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

The epidemiology of invasive pneumococcal disease in older adults in the post-PCV era. Has there been a herd effect?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Update on the Use of Conjugate Pneumococcal Vaccines in Childhood: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)†

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Stability of the pneumococcal population structure in Massachusetts as PCV13 was introduced

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Population Snapshot of EmergentStreptococcus pneumoniaeSerotype 19A in the United States, 2005

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

based on heuristic

inferred from DOI database lookup

Serotype replacement in disease after pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Changes in capsule and drug resistance of Pneumococci after introduction of PCV7, Japan, 2010-2013.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Efficacy of pneumococcal vaccination in adults: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

The effect of pneumococcal conjugate vaccines on the incidence of invasive pneumococcal disease caused by ten non-vaccine serotypes in Denmark

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Can the success of pneumococcal conjugate vaccines for the prevention of pneumococcal diseases in children be extrapolated to adults?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Efficacy of PPV23 in Preventing Pneumococcal Pneumonia in Adults at Increased Risk--A Systematic Review and Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Have changing pneumococcal vaccination programmes impacted disease in Ontario?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

rpoB gene sequence-based identification of aerobic Gram-positive cocci of the genera Streptococcus, Enterococcus, Gemella, Abiotrophia, and Granulicatella

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Pneumococcal transmission and disease in silico: a microsimulation model of the indirect effects of vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with streptococcus pneumoniae in children in Calgary, Canada.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Declining invasive pneumococcal disease in the U.S. elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Changing Epidemiology of Invasive Pneumococcal Disease in Canada, 1998–2007: Update from the Calgary‐Area Streptococcus pneumoniae Research (CASPER) Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Demonstration of the herd effect in adults after the implementation of pneumococcal vaccination with PCV13 in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Declining mortality from adult pneumococcal infections linked to children's vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2018.06.018

7 January 2021

Identifiers

10.1016/J.VACCINE.2018.06.018

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937245%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64137268&oldid=2034677802"